Glyburide Suppresses Inflammation-Related Colorectal Tumorigenesis Through Inhibition of NLRP3 Inflammasome
International Journal of Molecular Sciences · 30.10.2024 · 25 (21) · 11640
DOI: 10.3390/ijms252111640 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 30.10.2024. Verfasst von Toshihide Maeda und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Glyburide, Colorectal Neoplasms, Inflammasomes. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, SGH Cancer Research, Grants-in-Aid for Scientific Research JSPS KAKENHI.
Abstract (Originalsprache)
Colorectal cancer represents one of the most serious complications of inflammatory bowel disease. The NLRP3 inflammasome plays a pivotal role in the onset and progression of inflammatory bowel disease and is also implicated in colorectal cancer. This study aimed to investigate whether NLRP3 deficiency or glyburide, a sulfonylurea used for diabetes management and known as an NLRP3 inhibitor, could suppress colitis and its related colorectal tumorigenesis. Mice were divided into three groups: a control group, a glyburide group, and an NLRP3-deficient group. We investigated acute colitis and inflammation-related tumor models using azoxymethane and dextran sodium sulfate. In the colitis model, the colonic inflammation grade was significantly increased in NLRP3-deficient mice but not in mice administered glyburide. In the colorectal carcinogenesis model, fewer colorectal tumors were observed in both NLRP3-deficient and glyburide-treated groups. Additionally, a reduction in the expression levels of inflammatory cytokine genes was detected in the colonic mucosa of the mice of these groups. These findings suggest that NLRP3 deficiency may exacerbate acute colitis, while pharmacological inhibition, as well as deficiency of NLRP3, suppresses colitis-related tumorigenesis, presumably due to the attenuation of chronic inflammation in the colorectum. Glyburide holds promise as a potential chemopreventive agent for colitis-related colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan.
- Department of Tumor Pathology, Graduate School of Medicine, Gifu University, Gifu 501-1194, Japan.
ORCID-Profile: Yohei Shirakami, Daisuke Taguchi, Takao Miwa, Hiroyasu Sakai, Kosuke Mori, Hiroyuki Tomita
Förderung
- Japan Society for the Promotion of Science
- SGH Cancer Research
- Grants-in-Aid for Scientific Research JSPS KAKENHI
Zitieren
APA
Maeda, T., Shirakami, Y., Taguchi, D., Miwa, T., Kubota, M., Sakai, H., Ibuka, T., Mori, K., Tomita, H., & Shimizu, M. (2024). Glyburide Suppresses Inflammation-Related Colorectal Tumorigenesis Through Inhibition of NLRP3 Inflammasome. International Journal of Molecular Sciences, 25(21), 11640. https://doi.org/10.3390/ijms252111640
Vancouver
Maeda T, Shirakami Y, Taguchi D, Miwa T, Kubota M, Sakai H, et al. Glyburide Suppresses Inflammation-Related Colorectal Tumorigenesis Through Inhibition of NLRP3 Inflammasome. International Journal of Molecular Sciences. 2024;25(21):11640. doi:10.3390/ijms252111640
BibTeX
@article{Maeda2024,
author = {Maeda, Toshihide and Shirakami, Yohei and Taguchi, Daisuke and Miwa, Takao and Kubota, Masaya and Sakai, Hiroyasu and Ibuka, Takashi and Mori, Kosuke and Tomita, Hiroyuki and Shimizu, Masahito},
title = {Glyburide Suppresses Inflammation-Related Colorectal Tumorigenesis Through Inhibition of NLRP3 Inflammasome},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {21},
pages = {11640},
doi = {10.3390/ijms252111640}
}
EUVIMED